Global Guanylate Cyclase-C Agonists Market Research Report 2025(Status and Outlook)
Report Overview
Guanylate Cyclase-C (GC-C) agonists are a class of therapeutic agents that target the guanylate cyclase-C receptor, primarily expressed in the gastrointestinal tract. These drugs stimulate intracellular cyclic guanosine monophosphate (cGMP) production, leading to enhanced fluid secretion and reduced inflammation, making them effective in treating gastrointestinal disorders such as chronic idiopathic constipation (CIC), irritable bowel syndrome with constipation (IBS-C), and inflammatory bowel disease (IBD). The market for GC-C agonists has gained traction due to the growing prevalence of functional gastrointestinal disorders and the demand for targeted therapies with fewer systemic side effects compared to traditional laxatives or anti-inflammatory drugs. Key players in this space include linaclotide (Linzess) and plecanatide (Trulance), which dominate the market, supported by strong clinical efficacy and safety profiles. The market is expected to expand further with ongoing research into novel GC-C agonists and potential applications in additional GI conditions, though competition from biologics and generic alternatives could pose challenges. Regulatory approvals, reimbursement policies, and patient awareness will play critical roles in shaping future growth.
This report provides a deep insight into the global Guanylate Cyclase-C Agonists market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Guanylate Cyclase-C Agonists Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Guanylate Cyclase-C Agonists market in any manner.
Global Guanylate Cyclase-C Agonists Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott
Pfizer
Mylan N.V.
Johnson & Johnson
Teva Pharmaceutical Industries Ltd.
Sanofi
Novartis AG
Takeda Pharmaceutical Company Limited
GlaxoSmithKline
AstraZeneca
F. Hoffmann-La Roche Ltd.
Boehringer Ingelheim International GmbH.
Astellas Pharma Inc.
Allergan
Mitsubishi Tanabe Pharma Corporation
Kyowa Kirin Co.
Ltd.
Market Segmentation (by Type)
Injection
Tablet
Others
Market Segmentation (by Application)
Hospitals
Specialty Clinics
Homecare
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Guanylate Cyclase-C Agonists Market
Overview of the regional outlook of the Guanylate Cyclase-C Agonists Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Guanylate Cyclase-C Agonists Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Guanylate Cyclase-C Agonists, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Guanylate Cyclase-C (GC-C) agonists are a class of therapeutic agents that target the guanylate cyclase-C receptor, primarily expressed in the gastrointestinal tract. These drugs stimulate intracellular cyclic guanosine monophosphate (cGMP) production, leading to enhanced fluid secretion and reduced inflammation, making them effective in treating gastrointestinal disorders such as chronic idiopathic constipation (CIC), irritable bowel syndrome with constipation (IBS-C), and inflammatory bowel disease (IBD). The market for GC-C agonists has gained traction due to the growing prevalence of functional gastrointestinal disorders and the demand for targeted therapies with fewer systemic side effects compared to traditional laxatives or anti-inflammatory drugs. Key players in this space include linaclotide (Linzess) and plecanatide (Trulance), which dominate the market, supported by strong clinical efficacy and safety profiles. The market is expected to expand further with ongoing research into novel GC-C agonists and potential applications in additional GI conditions, though competition from biologics and generic alternatives could pose challenges. Regulatory approvals, reimbursement policies, and patient awareness will play critical roles in shaping future growth.
This report provides a deep insight into the global Guanylate Cyclase-C Agonists market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Guanylate Cyclase-C Agonists Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Guanylate Cyclase-C Agonists market in any manner.
Global Guanylate Cyclase-C Agonists Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott
Pfizer
Mylan N.V.
Johnson & Johnson
Teva Pharmaceutical Industries Ltd.
Sanofi
Novartis AG
Takeda Pharmaceutical Company Limited
GlaxoSmithKline
AstraZeneca
F. Hoffmann-La Roche Ltd.
Boehringer Ingelheim International GmbH.
Astellas Pharma Inc.
Allergan
Mitsubishi Tanabe Pharma Corporation
Kyowa Kirin Co.
Ltd.
Market Segmentation (by Type)
Injection
Tablet
Others
Market Segmentation (by Application)
Hospitals
Specialty Clinics
Homecare
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Guanylate Cyclase-C Agonists Market
Overview of the regional outlook of the Guanylate Cyclase-C Agonists Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Guanylate Cyclase-C Agonists Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Guanylate Cyclase-C Agonists, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Guanylate Cyclase-C Agonists
1.2 Key Market Segments
1.2.1 Guanylate Cyclase-C Agonists Segment by Type
1.2.2 Guanylate Cyclase-C Agonists Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GUANYLATE CYCLASE-C AGONISTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Guanylate Cyclase-C Agonists Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Guanylate Cyclase-C Agonists Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GUANYLATE CYCLASE-C AGONISTS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Guanylate Cyclase-C Agonists Product Life Cycle
3.3 Global Guanylate Cyclase-C Agonists Sales by Manufacturers (2020-2025)
3.4 Global Guanylate Cyclase-C Agonists Revenue Market Share by Manufacturers (2020-2025)
3.5 Guanylate Cyclase-C Agonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Guanylate Cyclase-C Agonists Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Guanylate Cyclase-C Agonists Market Competitive Situation and Trends
3.8.1 Guanylate Cyclase-C Agonists Market Concentration Rate
3.8.2 Global 5 and 10 Largest Guanylate Cyclase-C Agonists Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GUANYLATE CYCLASE-C AGONISTS INDUSTRY CHAIN ANALYSIS
4.1 Guanylate Cyclase-C Agonists Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GUANYLATE CYCLASE-C AGONISTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Guanylate Cyclase-C Agonists Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Guanylate Cyclase-C Agonists Market
5.7 ESG Ratings of Leading Companies
6 GUANYLATE CYCLASE-C AGONISTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Guanylate Cyclase-C Agonists Sales Market Share by Type (2020-2025)
6.3 Global Guanylate Cyclase-C Agonists Market Size Market Share by Type (2020-2025)
6.4 Global Guanylate Cyclase-C Agonists Price by Type (2020-2025)
7 GUANYLATE CYCLASE-C AGONISTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Guanylate Cyclase-C Agonists Market Sales by Application (2020-2025)
7.3 Global Guanylate Cyclase-C Agonists Market Size (M USD) by Application (2020-2025)
7.4 Global Guanylate Cyclase-C Agonists Sales Growth Rate by Application (2020-2025)
8 GUANYLATE CYCLASE-C AGONISTS MARKET SALES BY REGION
8.1 Global Guanylate Cyclase-C Agonists Sales by Region
8.1.1 Global Guanylate Cyclase-C Agonists Sales by Region
8.1.2 Global Guanylate Cyclase-C Agonists Sales Market Share by Region
8.2 Global Guanylate Cyclase-C Agonists Market Size by Region
8.2.1 Global Guanylate Cyclase-C Agonists Market Size by Region
8.2.2 Global Guanylate Cyclase-C Agonists Market Size Market Share by Region
8.3 North America
8.3.1 North America Guanylate Cyclase-C Agonists Sales by Country
8.3.2 North America Guanylate Cyclase-C Agonists Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Guanylate Cyclase-C Agonists Sales by Country
8.4.2 Europe Guanylate Cyclase-C Agonists Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Guanylate Cyclase-C Agonists Sales by Region
8.5.2 Asia Pacific Guanylate Cyclase-C Agonists Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Guanylate Cyclase-C Agonists Sales by Country
8.6.2 South America Guanylate Cyclase-C Agonists Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Guanylate Cyclase-C Agonists Sales by Region
8.7.2 Middle East and Africa Guanylate Cyclase-C Agonists Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GUANYLATE CYCLASE-C AGONISTS MARKET PRODUCTION BY REGION
9.1 Global Production of Guanylate Cyclase-C Agonists by Region(2020-2025)
9.2 Global Guanylate Cyclase-C Agonists Revenue Market Share by Region (2020-2025)
9.3 Global Guanylate Cyclase-C Agonists Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Guanylate Cyclase-C Agonists Production
9.4.1 North America Guanylate Cyclase-C Agonists Production Growth Rate (2020-2025)
9.4.2 North America Guanylate Cyclase-C Agonists Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Guanylate Cyclase-C Agonists Production
9.5.1 Europe Guanylate Cyclase-C Agonists Production Growth Rate (2020-2025)
9.5.2 Europe Guanylate Cyclase-C Agonists Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Guanylate Cyclase-C Agonists Production (2020-2025)
9.6.1 Japan Guanylate Cyclase-C Agonists Production Growth Rate (2020-2025)
9.6.2 Japan Guanylate Cyclase-C Agonists Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Guanylate Cyclase-C Agonists Production (2020-2025)
9.7.1 China Guanylate Cyclase-C Agonists Production Growth Rate (2020-2025)
9.7.2 China Guanylate Cyclase-C Agonists Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott
10.1.1 Abbott Basic Information
10.1.2 Abbott Guanylate Cyclase-C Agonists Product Overview
10.1.3 Abbott Guanylate Cyclase-C Agonists Product Market Performance
10.1.4 Abbott Business Overview
10.1.5 Abbott SWOT Analysis
10.1.6 Abbott Recent Developments
10.2 Pfizer
10.2.1 Pfizer Basic Information
10.2.2 Pfizer Guanylate Cyclase-C Agonists Product Overview
10.2.3 Pfizer Guanylate Cyclase-C Agonists Product Market Performance
10.2.4 Pfizer Business Overview
10.2.5 Pfizer SWOT Analysis
10.2.6 Pfizer Recent Developments
10.3 Mylan N.V.
10.3.1 Mylan N.V. Basic Information
10.3.2 Mylan N.V. Guanylate Cyclase-C Agonists Product Overview
10.3.3 Mylan N.V. Guanylate Cyclase-C Agonists Product Market Performance
10.3.4 Mylan N.V. Business Overview
10.3.5 Mylan N.V. SWOT Analysis
10.3.6 Mylan N.V. Recent Developments
10.4 Johnson and Johnson
10.4.1 Johnson and Johnson Basic Information
10.4.2 Johnson and Johnson Guanylate Cyclase-C Agonists Product Overview
10.4.3 Johnson and Johnson Guanylate Cyclase-C Agonists Product Market Performance
10.4.4 Johnson and Johnson Business Overview
10.4.5 Johnson and Johnson Recent Developments
10.5 Teva Pharmaceutical Industries Ltd.
10.5.1 Teva Pharmaceutical Industries Ltd. Basic Information
10.5.2 Teva Pharmaceutical Industries Ltd. Guanylate Cyclase-C Agonists Product Overview
10.5.3 Teva Pharmaceutical Industries Ltd. Guanylate Cyclase-C Agonists Product Market Performance
10.5.4 Teva Pharmaceutical Industries Ltd. Business Overview
10.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments
10.6 Sanofi
10.6.1 Sanofi Basic Information
10.6.2 Sanofi Guanylate Cyclase-C Agonists Product Overview
10.6.3 Sanofi Guanylate Cyclase-C Agonists Product Market Performance
10.6.4 Sanofi Business Overview
10.6.5 Sanofi Recent Developments
10.7 Novartis AG
10.7.1 Novartis AG Basic Information
10.7.2 Novartis AG Guanylate Cyclase-C Agonists Product Overview
10.7.3 Novartis AG Guanylate Cyclase-C Agonists Product Market Performance
10.7.4 Novartis AG Business Overview
10.7.5 Novartis AG Recent Developments
10.8 Takeda Pharmaceutical Company Limited
10.8.1 Takeda Pharmaceutical Company Limited Basic Information
10.8.2 Takeda Pharmaceutical Company Limited Guanylate Cyclase-C Agonists Product Overview
10.8.3 Takeda Pharmaceutical Company Limited Guanylate Cyclase-C Agonists Product Market Performance
10.8.4 Takeda Pharmaceutical Company Limited Business Overview
10.8.5 Takeda Pharmaceutical Company Limited Recent Developments
10.9 GlaxoSmithKline
10.9.1 GlaxoSmithKline Basic Information
10.9.2 GlaxoSmithKline Guanylate Cyclase-C Agonists Product Overview
10.9.3 GlaxoSmithKline Guanylate Cyclase-C Agonists Product Market Performance
10.9.4 GlaxoSmithKline Business Overview
10.9.5 GlaxoSmithKline Recent Developments
10.10 AstraZeneca
10.10.1 AstraZeneca Basic Information
10.10.2 AstraZeneca Guanylate Cyclase-C Agonists Product Overview
10.10.3 AstraZeneca Guanylate Cyclase-C Agonists Product Market Performance
10.10.4 AstraZeneca Business Overview
10.10.5 AstraZeneca Recent Developments
10.11 F. Hoffmann-La Roche Ltd.
10.11.1 F. Hoffmann-La Roche Ltd. Basic Information
10.11.2 F. Hoffmann-La Roche Ltd. Guanylate Cyclase-C Agonists Product Overview
10.11.3 F. Hoffmann-La Roche Ltd. Guanylate Cyclase-C Agonists Product Market Performance
10.11.4 F. Hoffmann-La Roche Ltd. Business Overview
10.11.5 F. Hoffmann-La Roche Ltd. Recent Developments
10.12 Boehringer Ingelheim International GmbH.
10.12.1 Boehringer Ingelheim International GmbH. Basic Information
10.12.2 Boehringer Ingelheim International GmbH. Guanylate Cyclase-C Agonists Product Overview
10.12.3 Boehringer Ingelheim International GmbH. Guanylate Cyclase-C Agonists Product Market Performance
10.12.4 Boehringer Ingelheim International GmbH. Business Overview
10.12.5 Boehringer Ingelheim International GmbH. Recent Developments
10.13 Astellas Pharma Inc.
10.13.1 Astellas Pharma Inc. Basic Information
10.13.2 Astellas Pharma Inc. Guanylate Cyclase-C Agonists Product Overview
10.13.3 Astellas Pharma Inc. Guanylate Cyclase-C Agonists Product Market Performance
10.13.4 Astellas Pharma Inc. Business Overview
10.13.5 Astellas Pharma Inc. Recent Developments
10.14 Allergan
10.14.1 Allergan Basic Information
10.14.2 Allergan Guanylate Cyclase-C Agonists Product Overview
10.14.3 Allergan Guanylate Cyclase-C Agonists Product Market Performance
10.14.4 Allergan Business Overview
10.14.5 Allergan Recent Developments
10.15 Mitsubishi Tanabe Pharma Corporation
10.15.1 Mitsubishi Tanabe Pharma Corporation Basic Information
10.15.2 Mitsubishi Tanabe Pharma Corporation Guanylate Cyclase-C Agonists Product Overview
10.15.3 Mitsubishi Tanabe Pharma Corporation Guanylate Cyclase-C Agonists Product Market Performance
10.15.4 Mitsubishi Tanabe Pharma Corporation Business Overview
10.15.5 Mitsubishi Tanabe Pharma Corporation Recent Developments
10.16 Kyowa Kirin Co.
10.16.1 Kyowa Kirin Co. Basic Information
10.16.2 Kyowa Kirin Co. Guanylate Cyclase-C Agonists Product Overview
10.16.3 Kyowa Kirin Co. Guanylate Cyclase-C Agonists Product Market Performance
10.16.4 Kyowa Kirin Co. Business Overview
10.16.5 Kyowa Kirin Co. Recent Developments
10.17 Ltd.
10.17.1 Ltd. Basic Information
10.17.2 Ltd. Guanylate Cyclase-C Agonists Product Overview
10.17.3 Ltd. Guanylate Cyclase-C Agonists Product Market Performance
10.17.4 Ltd. Business Overview
10.17.5 Ltd. Recent Developments
11 GUANYLATE CYCLASE-C AGONISTS MARKET FORECAST BY REGION
11.1 Global Guanylate Cyclase-C Agonists Market Size Forecast
11.2 Global Guanylate Cyclase-C Agonists Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Guanylate Cyclase-C Agonists Market Size Forecast by Country
11.2.3 Asia Pacific Guanylate Cyclase-C Agonists Market Size Forecast by Region
11.2.4 South America Guanylate Cyclase-C Agonists Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Guanylate Cyclase-C Agonists by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Guanylate Cyclase-C Agonists Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Guanylate Cyclase-C Agonists by Type (2026-2033)
12.1.2 Global Guanylate Cyclase-C Agonists Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Guanylate Cyclase-C Agonists by Type (2026-2033)
12.2 Global Guanylate Cyclase-C Agonists Market Forecast by Application (2026-2033)
12.2.1 Global Guanylate Cyclase-C Agonists Sales (K Units) Forecast by Application
12.2.2 Global Guanylate Cyclase-C Agonists Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Guanylate Cyclase-C Agonists
1.2 Key Market Segments
1.2.1 Guanylate Cyclase-C Agonists Segment by Type
1.2.2 Guanylate Cyclase-C Agonists Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GUANYLATE CYCLASE-C AGONISTS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Guanylate Cyclase-C Agonists Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Guanylate Cyclase-C Agonists Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GUANYLATE CYCLASE-C AGONISTS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Guanylate Cyclase-C Agonists Product Life Cycle
3.3 Global Guanylate Cyclase-C Agonists Sales by Manufacturers (2020-2025)
3.4 Global Guanylate Cyclase-C Agonists Revenue Market Share by Manufacturers (2020-2025)
3.5 Guanylate Cyclase-C Agonists Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Guanylate Cyclase-C Agonists Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Guanylate Cyclase-C Agonists Market Competitive Situation and Trends
3.8.1 Guanylate Cyclase-C Agonists Market Concentration Rate
3.8.2 Global 5 and 10 Largest Guanylate Cyclase-C Agonists Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GUANYLATE CYCLASE-C AGONISTS INDUSTRY CHAIN ANALYSIS
4.1 Guanylate Cyclase-C Agonists Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GUANYLATE CYCLASE-C AGONISTS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Guanylate Cyclase-C Agonists Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Guanylate Cyclase-C Agonists Market
5.7 ESG Ratings of Leading Companies
6 GUANYLATE CYCLASE-C AGONISTS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Guanylate Cyclase-C Agonists Sales Market Share by Type (2020-2025)
6.3 Global Guanylate Cyclase-C Agonists Market Size Market Share by Type (2020-2025)
6.4 Global Guanylate Cyclase-C Agonists Price by Type (2020-2025)
7 GUANYLATE CYCLASE-C AGONISTS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Guanylate Cyclase-C Agonists Market Sales by Application (2020-2025)
7.3 Global Guanylate Cyclase-C Agonists Market Size (M USD) by Application (2020-2025)
7.4 Global Guanylate Cyclase-C Agonists Sales Growth Rate by Application (2020-2025)
8 GUANYLATE CYCLASE-C AGONISTS MARKET SALES BY REGION
8.1 Global Guanylate Cyclase-C Agonists Sales by Region
8.1.1 Global Guanylate Cyclase-C Agonists Sales by Region
8.1.2 Global Guanylate Cyclase-C Agonists Sales Market Share by Region
8.2 Global Guanylate Cyclase-C Agonists Market Size by Region
8.2.1 Global Guanylate Cyclase-C Agonists Market Size by Region
8.2.2 Global Guanylate Cyclase-C Agonists Market Size Market Share by Region
8.3 North America
8.3.1 North America Guanylate Cyclase-C Agonists Sales by Country
8.3.2 North America Guanylate Cyclase-C Agonists Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Guanylate Cyclase-C Agonists Sales by Country
8.4.2 Europe Guanylate Cyclase-C Agonists Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Guanylate Cyclase-C Agonists Sales by Region
8.5.2 Asia Pacific Guanylate Cyclase-C Agonists Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Guanylate Cyclase-C Agonists Sales by Country
8.6.2 South America Guanylate Cyclase-C Agonists Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Guanylate Cyclase-C Agonists Sales by Region
8.7.2 Middle East and Africa Guanylate Cyclase-C Agonists Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GUANYLATE CYCLASE-C AGONISTS MARKET PRODUCTION BY REGION
9.1 Global Production of Guanylate Cyclase-C Agonists by Region(2020-2025)
9.2 Global Guanylate Cyclase-C Agonists Revenue Market Share by Region (2020-2025)
9.3 Global Guanylate Cyclase-C Agonists Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Guanylate Cyclase-C Agonists Production
9.4.1 North America Guanylate Cyclase-C Agonists Production Growth Rate (2020-2025)
9.4.2 North America Guanylate Cyclase-C Agonists Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Guanylate Cyclase-C Agonists Production
9.5.1 Europe Guanylate Cyclase-C Agonists Production Growth Rate (2020-2025)
9.5.2 Europe Guanylate Cyclase-C Agonists Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Guanylate Cyclase-C Agonists Production (2020-2025)
9.6.1 Japan Guanylate Cyclase-C Agonists Production Growth Rate (2020-2025)
9.6.2 Japan Guanylate Cyclase-C Agonists Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Guanylate Cyclase-C Agonists Production (2020-2025)
9.7.1 China Guanylate Cyclase-C Agonists Production Growth Rate (2020-2025)
9.7.2 China Guanylate Cyclase-C Agonists Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Abbott
10.1.1 Abbott Basic Information
10.1.2 Abbott Guanylate Cyclase-C Agonists Product Overview
10.1.3 Abbott Guanylate Cyclase-C Agonists Product Market Performance
10.1.4 Abbott Business Overview
10.1.5 Abbott SWOT Analysis
10.1.6 Abbott Recent Developments
10.2 Pfizer
10.2.1 Pfizer Basic Information
10.2.2 Pfizer Guanylate Cyclase-C Agonists Product Overview
10.2.3 Pfizer Guanylate Cyclase-C Agonists Product Market Performance
10.2.4 Pfizer Business Overview
10.2.5 Pfizer SWOT Analysis
10.2.6 Pfizer Recent Developments
10.3 Mylan N.V.
10.3.1 Mylan N.V. Basic Information
10.3.2 Mylan N.V. Guanylate Cyclase-C Agonists Product Overview
10.3.3 Mylan N.V. Guanylate Cyclase-C Agonists Product Market Performance
10.3.4 Mylan N.V. Business Overview
10.3.5 Mylan N.V. SWOT Analysis
10.3.6 Mylan N.V. Recent Developments
10.4 Johnson and Johnson
10.4.1 Johnson and Johnson Basic Information
10.4.2 Johnson and Johnson Guanylate Cyclase-C Agonists Product Overview
10.4.3 Johnson and Johnson Guanylate Cyclase-C Agonists Product Market Performance
10.4.4 Johnson and Johnson Business Overview
10.4.5 Johnson and Johnson Recent Developments
10.5 Teva Pharmaceutical Industries Ltd.
10.5.1 Teva Pharmaceutical Industries Ltd. Basic Information
10.5.2 Teva Pharmaceutical Industries Ltd. Guanylate Cyclase-C Agonists Product Overview
10.5.3 Teva Pharmaceutical Industries Ltd. Guanylate Cyclase-C Agonists Product Market Performance
10.5.4 Teva Pharmaceutical Industries Ltd. Business Overview
10.5.5 Teva Pharmaceutical Industries Ltd. Recent Developments
10.6 Sanofi
10.6.1 Sanofi Basic Information
10.6.2 Sanofi Guanylate Cyclase-C Agonists Product Overview
10.6.3 Sanofi Guanylate Cyclase-C Agonists Product Market Performance
10.6.4 Sanofi Business Overview
10.6.5 Sanofi Recent Developments
10.7 Novartis AG
10.7.1 Novartis AG Basic Information
10.7.2 Novartis AG Guanylate Cyclase-C Agonists Product Overview
10.7.3 Novartis AG Guanylate Cyclase-C Agonists Product Market Performance
10.7.4 Novartis AG Business Overview
10.7.5 Novartis AG Recent Developments
10.8 Takeda Pharmaceutical Company Limited
10.8.1 Takeda Pharmaceutical Company Limited Basic Information
10.8.2 Takeda Pharmaceutical Company Limited Guanylate Cyclase-C Agonists Product Overview
10.8.3 Takeda Pharmaceutical Company Limited Guanylate Cyclase-C Agonists Product Market Performance
10.8.4 Takeda Pharmaceutical Company Limited Business Overview
10.8.5 Takeda Pharmaceutical Company Limited Recent Developments
10.9 GlaxoSmithKline
10.9.1 GlaxoSmithKline Basic Information
10.9.2 GlaxoSmithKline Guanylate Cyclase-C Agonists Product Overview
10.9.3 GlaxoSmithKline Guanylate Cyclase-C Agonists Product Market Performance
10.9.4 GlaxoSmithKline Business Overview
10.9.5 GlaxoSmithKline Recent Developments
10.10 AstraZeneca
10.10.1 AstraZeneca Basic Information
10.10.2 AstraZeneca Guanylate Cyclase-C Agonists Product Overview
10.10.3 AstraZeneca Guanylate Cyclase-C Agonists Product Market Performance
10.10.4 AstraZeneca Business Overview
10.10.5 AstraZeneca Recent Developments
10.11 F. Hoffmann-La Roche Ltd.
10.11.1 F. Hoffmann-La Roche Ltd. Basic Information
10.11.2 F. Hoffmann-La Roche Ltd. Guanylate Cyclase-C Agonists Product Overview
10.11.3 F. Hoffmann-La Roche Ltd. Guanylate Cyclase-C Agonists Product Market Performance
10.11.4 F. Hoffmann-La Roche Ltd. Business Overview
10.11.5 F. Hoffmann-La Roche Ltd. Recent Developments
10.12 Boehringer Ingelheim International GmbH.
10.12.1 Boehringer Ingelheim International GmbH. Basic Information
10.12.2 Boehringer Ingelheim International GmbH. Guanylate Cyclase-C Agonists Product Overview
10.12.3 Boehringer Ingelheim International GmbH. Guanylate Cyclase-C Agonists Product Market Performance
10.12.4 Boehringer Ingelheim International GmbH. Business Overview
10.12.5 Boehringer Ingelheim International GmbH. Recent Developments
10.13 Astellas Pharma Inc.
10.13.1 Astellas Pharma Inc. Basic Information
10.13.2 Astellas Pharma Inc. Guanylate Cyclase-C Agonists Product Overview
10.13.3 Astellas Pharma Inc. Guanylate Cyclase-C Agonists Product Market Performance
10.13.4 Astellas Pharma Inc. Business Overview
10.13.5 Astellas Pharma Inc. Recent Developments
10.14 Allergan
10.14.1 Allergan Basic Information
10.14.2 Allergan Guanylate Cyclase-C Agonists Product Overview
10.14.3 Allergan Guanylate Cyclase-C Agonists Product Market Performance
10.14.4 Allergan Business Overview
10.14.5 Allergan Recent Developments
10.15 Mitsubishi Tanabe Pharma Corporation
10.15.1 Mitsubishi Tanabe Pharma Corporation Basic Information
10.15.2 Mitsubishi Tanabe Pharma Corporation Guanylate Cyclase-C Agonists Product Overview
10.15.3 Mitsubishi Tanabe Pharma Corporation Guanylate Cyclase-C Agonists Product Market Performance
10.15.4 Mitsubishi Tanabe Pharma Corporation Business Overview
10.15.5 Mitsubishi Tanabe Pharma Corporation Recent Developments
10.16 Kyowa Kirin Co.
10.16.1 Kyowa Kirin Co. Basic Information
10.16.2 Kyowa Kirin Co. Guanylate Cyclase-C Agonists Product Overview
10.16.3 Kyowa Kirin Co. Guanylate Cyclase-C Agonists Product Market Performance
10.16.4 Kyowa Kirin Co. Business Overview
10.16.5 Kyowa Kirin Co. Recent Developments
10.17 Ltd.
10.17.1 Ltd. Basic Information
10.17.2 Ltd. Guanylate Cyclase-C Agonists Product Overview
10.17.3 Ltd. Guanylate Cyclase-C Agonists Product Market Performance
10.17.4 Ltd. Business Overview
10.17.5 Ltd. Recent Developments
11 GUANYLATE CYCLASE-C AGONISTS MARKET FORECAST BY REGION
11.1 Global Guanylate Cyclase-C Agonists Market Size Forecast
11.2 Global Guanylate Cyclase-C Agonists Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Guanylate Cyclase-C Agonists Market Size Forecast by Country
11.2.3 Asia Pacific Guanylate Cyclase-C Agonists Market Size Forecast by Region
11.2.4 South America Guanylate Cyclase-C Agonists Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Guanylate Cyclase-C Agonists by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Guanylate Cyclase-C Agonists Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Guanylate Cyclase-C Agonists by Type (2026-2033)
12.1.2 Global Guanylate Cyclase-C Agonists Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Guanylate Cyclase-C Agonists by Type (2026-2033)
12.2 Global Guanylate Cyclase-C Agonists Market Forecast by Application (2026-2033)
12.2.1 Global Guanylate Cyclase-C Agonists Sales (K Units) Forecast by Application
12.2.2 Global Guanylate Cyclase-C Agonists Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Guanylate Cyclase-C Agonists Market Size Comparison by Region (M USD)
Table 5. Global Guanylate Cyclase-C Agonists Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Guanylate Cyclase-C Agonists Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Guanylate Cyclase-C Agonists Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Guanylate Cyclase-C Agonists Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Guanylate Cyclase-C Agonists as of 2024)
Table 10. Global Market Guanylate Cyclase-C Agonists Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Guanylate Cyclase-C Agonists Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Guanylate Cyclase-C Agonists Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Guanylate Cyclase-C Agonists Sales by Type (K Units)
Table 26. Global Guanylate Cyclase-C Agonists Market Size by Type (M USD)
Table 27. Global Guanylate Cyclase-C Agonists Sales (K Units) by Type (2020-2025)
Table 28. Global Guanylate Cyclase-C Agonists Sales Market Share by Type (2020-2025)
Table 29. Global Guanylate Cyclase-C Agonists Market Size (M USD) by Type (2020-2025)
Table 30. Global Guanylate Cyclase-C Agonists Market Size Share by Type (2020-2025)
Table 31. Global Guanylate Cyclase-C Agonists Price (USD/Unit) by Type (2020-2025)
Table 32. Global Guanylate Cyclase-C Agonists Sales (K Units) by Application
Table 33. Global Guanylate Cyclase-C Agonists Market Size by Application
Table 34. Global Guanylate Cyclase-C Agonists Sales by Application (2020-2025) & (K Units)
Table 35. Global Guanylate Cyclase-C Agonists Sales Market Share by Application (2020-2025)
Table 36. Global Guanylate Cyclase-C Agonists Market Size by Application (2020-2025) & (M USD)
Table 37. Global Guanylate Cyclase-C Agonists Market Share by Application (2020-2025)
Table 38. Global Guanylate Cyclase-C Agonists Sales Growth Rate by Application (2020-2025)
Table 39. Global Guanylate Cyclase-C Agonists Sales by Region (2020-2025) & (K Units)
Table 40. Global Guanylate Cyclase-C Agonists Sales Market Share by Region (2020-2025)
Table 41. Global Guanylate Cyclase-C Agonists Market Size by Region (2020-2025) & (M USD)
Table 42. Global Guanylate Cyclase-C Agonists Market Size Market Share by Region (2020-2025)
Table 43. North America Guanylate Cyclase-C Agonists Sales by Country (2020-2025) & (K Units)
Table 44. North America Guanylate Cyclase-C Agonists Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Guanylate Cyclase-C Agonists Sales by Country (2020-2025) & (K Units)
Table 46. Europe Guanylate Cyclase-C Agonists Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Guanylate Cyclase-C Agonists Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Guanylate Cyclase-C Agonists Market Size by Region (2020-2025) & (M USD)
Table 49. South America Guanylate Cyclase-C Agonists Sales by Country (2020-2025) & (K Units)
Table 50. South America Guanylate Cyclase-C Agonists Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Guanylate Cyclase-C Agonists Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Guanylate Cyclase-C Agonists Market Size by Region (2020-2025) & (M USD)
Table 53. Global Guanylate Cyclase-C Agonists Production (K Units) by Region(2020-2025)
Table 54. Global Guanylate Cyclase-C Agonists Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Guanylate Cyclase-C Agonists Revenue Market Share by Region (2020-2025)
Table 56. Global Guanylate Cyclase-C Agonists Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Guanylate Cyclase-C Agonists Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Guanylate Cyclase-C Agonists Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Guanylate Cyclase-C Agonists Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Guanylate Cyclase-C Agonists Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Abbott Basic Information
Table 62. Abbott Guanylate Cyclase-C Agonists Product Overview
Table 63. Abbott Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Abbott Business Overview
Table 65. Abbott SWOT Analysis
Table 66. Abbott Recent Developments
Table 67. Pfizer Basic Information
Table 68. Pfizer Guanylate Cyclase-C Agonists Product Overview
Table 69. Pfizer Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Pfizer Business Overview
Table 71. Pfizer SWOT Analysis
Table 72. Pfizer Recent Developments
Table 73. Mylan N.V. Basic Information
Table 74. Mylan N.V. Guanylate Cyclase-C Agonists Product Overview
Table 75. Mylan N.V. Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Mylan N.V. Business Overview
Table 77. Mylan N.V. SWOT Analysis
Table 78. Mylan N.V. Recent Developments
Table 79. Johnson and Johnson Basic Information
Table 80. Johnson and Johnson Guanylate Cyclase-C Agonists Product Overview
Table 81. Johnson and Johnson Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Johnson and Johnson Business Overview
Table 83. Johnson and Johnson Recent Developments
Table 84. Teva Pharmaceutical Industries Ltd. Basic Information
Table 85. Teva Pharmaceutical Industries Ltd. Guanylate Cyclase-C Agonists Product Overview
Table 86. Teva Pharmaceutical Industries Ltd. Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Teva Pharmaceutical Industries Ltd. Business Overview
Table 88. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 89. Sanofi Basic Information
Table 90. Sanofi Guanylate Cyclase-C Agonists Product Overview
Table 91. Sanofi Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Sanofi Business Overview
Table 93. Sanofi Recent Developments
Table 94. Novartis AG Basic Information
Table 95. Novartis AG Guanylate Cyclase-C Agonists Product Overview
Table 96. Novartis AG Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Novartis AG Business Overview
Table 98. Novartis AG Recent Developments
Table 99. Takeda Pharmaceutical Company Limited Basic Information
Table 100. Takeda Pharmaceutical Company Limited Guanylate Cyclase-C Agonists Product Overview
Table 101. Takeda Pharmaceutical Company Limited Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Takeda Pharmaceutical Company Limited Business Overview
Table 103. Takeda Pharmaceutical Company Limited Recent Developments
Table 104. GlaxoSmithKline Basic Information
Table 105. GlaxoSmithKline Guanylate Cyclase-C Agonists Product Overview
Table 106. GlaxoSmithKline Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. GlaxoSmithKline Business Overview
Table 108. GlaxoSmithKline Recent Developments
Table 109. AstraZeneca Basic Information
Table 110. AstraZeneca Guanylate Cyclase-C Agonists Product Overview
Table 111. AstraZeneca Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. AstraZeneca Business Overview
Table 113. AstraZeneca Recent Developments
Table 114. F. Hoffmann-La Roche Ltd. Basic Information
Table 115. F. Hoffmann-La Roche Ltd. Guanylate Cyclase-C Agonists Product Overview
Table 116. F. Hoffmann-La Roche Ltd. Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. F. Hoffmann-La Roche Ltd. Business Overview
Table 118. F. Hoffmann-La Roche Ltd. Recent Developments
Table 119. Boehringer Ingelheim International GmbH. Basic Information
Table 120. Boehringer Ingelheim International GmbH. Guanylate Cyclase-C Agonists Product Overview
Table 121. Boehringer Ingelheim International GmbH. Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Boehringer Ingelheim International GmbH. Business Overview
Table 123. Boehringer Ingelheim International GmbH. Recent Developments
Table 124. Astellas Pharma Inc. Basic Information
Table 125. Astellas Pharma Inc. Guanylate Cyclase-C Agonists Product Overview
Table 126. Astellas Pharma Inc. Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Astellas Pharma Inc. Business Overview
Table 128. Astellas Pharma Inc. Recent Developments
Table 129. Allergan Basic Information
Table 130. Allergan Guanylate Cyclase-C Agonists Product Overview
Table 131. Allergan Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Allergan Business Overview
Table 133. Allergan Recent Developments
Table 134. Mitsubishi Tanabe Pharma Corporation Basic Information
Table 135. Mitsubishi Tanabe Pharma Corporation Guanylate Cyclase-C Agonists Product Overview
Table 136. Mitsubishi Tanabe Pharma Corporation Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Mitsubishi Tanabe Pharma Corporation Business Overview
Table 138. Mitsubishi Tanabe Pharma Corporation Recent Developments
Table 139. Kyowa Kirin Co. Basic Information
Table 140. Kyowa Kirin Co. Guanylate Cyclase-C Agonists Product Overview
Table 141. Kyowa Kirin Co. Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Kyowa Kirin Co. Business Overview
Table 143. Kyowa Kirin Co. Recent Developments
Table 144. Ltd. Basic Information
Table 145. Ltd. Guanylate Cyclase-C Agonists Product Overview
Table 146. Ltd. Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Ltd. Business Overview
Table 148. Ltd. Recent Developments
Table 149. Global Guanylate Cyclase-C Agonists Sales Forecast by Region (2026-2033) & (K Units)
Table 150. Global Guanylate Cyclase-C Agonists Market Size Forecast by Region (2026-2033) & (M USD)
Table 151. North America Guanylate Cyclase-C Agonists Sales Forecast by Country (2026-2033) & (K Units)
Table 152. North America Guanylate Cyclase-C Agonists Market Size Forecast by Country (2026-2033) & (M USD)
Table 153. Europe Guanylate Cyclase-C Agonists Sales Forecast by Country (2026-2033) & (K Units)
Table 154. Europe Guanylate Cyclase-C Agonists Market Size Forecast by Country (2026-2033) & (M USD)
Table 155. Asia Pacific Guanylate Cyclase-C Agonists Sales Forecast by Region (2026-2033) & (K Units)
Table 156. Asia Pacific Guanylate Cyclase-C Agonists Market Size Forecast by Region (2026-2033) & (M USD)
Table 157. South America Guanylate Cyclase-C Agonists Sales Forecast by Country (2026-2033) & (K Units)
Table 158. South America Guanylate Cyclase-C Agonists Market Size Forecast by Country (2026-2033) & (M USD)
Table 159. Middle East and Africa Guanylate Cyclase-C Agonists Sales Forecast by Country (2026-2033) & (Units)
Table 160. Middle East and Africa Guanylate Cyclase-C Agonists Market Size Forecast by Country (2026-2033) & (M USD)
Table 161. Global Guanylate Cyclase-C Agonists Sales Forecast by Type (2026-2033) & (K Units)
Table 162. Global Guanylate Cyclase-C Agonists Market Size Forecast by Type (2026-2033) & (M USD)
Table 163. Global Guanylate Cyclase-C Agonists Price Forecast by Type (2026-2033) & (USD/Unit)
Table 164. Global Guanylate Cyclase-C Agonists Sales (K Units) Forecast by Application (2026-2033)
Table 165. Global Guanylate Cyclase-C Agonists Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Guanylate Cyclase-C Agonists Market Size Comparison by Region (M USD)
Table 5. Global Guanylate Cyclase-C Agonists Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Guanylate Cyclase-C Agonists Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Guanylate Cyclase-C Agonists Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Guanylate Cyclase-C Agonists Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Guanylate Cyclase-C Agonists as of 2024)
Table 10. Global Market Guanylate Cyclase-C Agonists Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Guanylate Cyclase-C Agonists Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Guanylate Cyclase-C Agonists Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Guanylate Cyclase-C Agonists Sales by Type (K Units)
Table 26. Global Guanylate Cyclase-C Agonists Market Size by Type (M USD)
Table 27. Global Guanylate Cyclase-C Agonists Sales (K Units) by Type (2020-2025)
Table 28. Global Guanylate Cyclase-C Agonists Sales Market Share by Type (2020-2025)
Table 29. Global Guanylate Cyclase-C Agonists Market Size (M USD) by Type (2020-2025)
Table 30. Global Guanylate Cyclase-C Agonists Market Size Share by Type (2020-2025)
Table 31. Global Guanylate Cyclase-C Agonists Price (USD/Unit) by Type (2020-2025)
Table 32. Global Guanylate Cyclase-C Agonists Sales (K Units) by Application
Table 33. Global Guanylate Cyclase-C Agonists Market Size by Application
Table 34. Global Guanylate Cyclase-C Agonists Sales by Application (2020-2025) & (K Units)
Table 35. Global Guanylate Cyclase-C Agonists Sales Market Share by Application (2020-2025)
Table 36. Global Guanylate Cyclase-C Agonists Market Size by Application (2020-2025) & (M USD)
Table 37. Global Guanylate Cyclase-C Agonists Market Share by Application (2020-2025)
Table 38. Global Guanylate Cyclase-C Agonists Sales Growth Rate by Application (2020-2025)
Table 39. Global Guanylate Cyclase-C Agonists Sales by Region (2020-2025) & (K Units)
Table 40. Global Guanylate Cyclase-C Agonists Sales Market Share by Region (2020-2025)
Table 41. Global Guanylate Cyclase-C Agonists Market Size by Region (2020-2025) & (M USD)
Table 42. Global Guanylate Cyclase-C Agonists Market Size Market Share by Region (2020-2025)
Table 43. North America Guanylate Cyclase-C Agonists Sales by Country (2020-2025) & (K Units)
Table 44. North America Guanylate Cyclase-C Agonists Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Guanylate Cyclase-C Agonists Sales by Country (2020-2025) & (K Units)
Table 46. Europe Guanylate Cyclase-C Agonists Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Guanylate Cyclase-C Agonists Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Guanylate Cyclase-C Agonists Market Size by Region (2020-2025) & (M USD)
Table 49. South America Guanylate Cyclase-C Agonists Sales by Country (2020-2025) & (K Units)
Table 50. South America Guanylate Cyclase-C Agonists Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Guanylate Cyclase-C Agonists Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Guanylate Cyclase-C Agonists Market Size by Region (2020-2025) & (M USD)
Table 53. Global Guanylate Cyclase-C Agonists Production (K Units) by Region(2020-2025)
Table 54. Global Guanylate Cyclase-C Agonists Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Guanylate Cyclase-C Agonists Revenue Market Share by Region (2020-2025)
Table 56. Global Guanylate Cyclase-C Agonists Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Guanylate Cyclase-C Agonists Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Guanylate Cyclase-C Agonists Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Guanylate Cyclase-C Agonists Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Guanylate Cyclase-C Agonists Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Abbott Basic Information
Table 62. Abbott Guanylate Cyclase-C Agonists Product Overview
Table 63. Abbott Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Abbott Business Overview
Table 65. Abbott SWOT Analysis
Table 66. Abbott Recent Developments
Table 67. Pfizer Basic Information
Table 68. Pfizer Guanylate Cyclase-C Agonists Product Overview
Table 69. Pfizer Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Pfizer Business Overview
Table 71. Pfizer SWOT Analysis
Table 72. Pfizer Recent Developments
Table 73. Mylan N.V. Basic Information
Table 74. Mylan N.V. Guanylate Cyclase-C Agonists Product Overview
Table 75. Mylan N.V. Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Mylan N.V. Business Overview
Table 77. Mylan N.V. SWOT Analysis
Table 78. Mylan N.V. Recent Developments
Table 79. Johnson and Johnson Basic Information
Table 80. Johnson and Johnson Guanylate Cyclase-C Agonists Product Overview
Table 81. Johnson and Johnson Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Johnson and Johnson Business Overview
Table 83. Johnson and Johnson Recent Developments
Table 84. Teva Pharmaceutical Industries Ltd. Basic Information
Table 85. Teva Pharmaceutical Industries Ltd. Guanylate Cyclase-C Agonists Product Overview
Table 86. Teva Pharmaceutical Industries Ltd. Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Teva Pharmaceutical Industries Ltd. Business Overview
Table 88. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 89. Sanofi Basic Information
Table 90. Sanofi Guanylate Cyclase-C Agonists Product Overview
Table 91. Sanofi Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Sanofi Business Overview
Table 93. Sanofi Recent Developments
Table 94. Novartis AG Basic Information
Table 95. Novartis AG Guanylate Cyclase-C Agonists Product Overview
Table 96. Novartis AG Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Novartis AG Business Overview
Table 98. Novartis AG Recent Developments
Table 99. Takeda Pharmaceutical Company Limited Basic Information
Table 100. Takeda Pharmaceutical Company Limited Guanylate Cyclase-C Agonists Product Overview
Table 101. Takeda Pharmaceutical Company Limited Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Takeda Pharmaceutical Company Limited Business Overview
Table 103. Takeda Pharmaceutical Company Limited Recent Developments
Table 104. GlaxoSmithKline Basic Information
Table 105. GlaxoSmithKline Guanylate Cyclase-C Agonists Product Overview
Table 106. GlaxoSmithKline Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. GlaxoSmithKline Business Overview
Table 108. GlaxoSmithKline Recent Developments
Table 109. AstraZeneca Basic Information
Table 110. AstraZeneca Guanylate Cyclase-C Agonists Product Overview
Table 111. AstraZeneca Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. AstraZeneca Business Overview
Table 113. AstraZeneca Recent Developments
Table 114. F. Hoffmann-La Roche Ltd. Basic Information
Table 115. F. Hoffmann-La Roche Ltd. Guanylate Cyclase-C Agonists Product Overview
Table 116. F. Hoffmann-La Roche Ltd. Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. F. Hoffmann-La Roche Ltd. Business Overview
Table 118. F. Hoffmann-La Roche Ltd. Recent Developments
Table 119. Boehringer Ingelheim International GmbH. Basic Information
Table 120. Boehringer Ingelheim International GmbH. Guanylate Cyclase-C Agonists Product Overview
Table 121. Boehringer Ingelheim International GmbH. Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Boehringer Ingelheim International GmbH. Business Overview
Table 123. Boehringer Ingelheim International GmbH. Recent Developments
Table 124. Astellas Pharma Inc. Basic Information
Table 125. Astellas Pharma Inc. Guanylate Cyclase-C Agonists Product Overview
Table 126. Astellas Pharma Inc. Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Astellas Pharma Inc. Business Overview
Table 128. Astellas Pharma Inc. Recent Developments
Table 129. Allergan Basic Information
Table 130. Allergan Guanylate Cyclase-C Agonists Product Overview
Table 131. Allergan Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Allergan Business Overview
Table 133. Allergan Recent Developments
Table 134. Mitsubishi Tanabe Pharma Corporation Basic Information
Table 135. Mitsubishi Tanabe Pharma Corporation Guanylate Cyclase-C Agonists Product Overview
Table 136. Mitsubishi Tanabe Pharma Corporation Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Mitsubishi Tanabe Pharma Corporation Business Overview
Table 138. Mitsubishi Tanabe Pharma Corporation Recent Developments
Table 139. Kyowa Kirin Co. Basic Information
Table 140. Kyowa Kirin Co. Guanylate Cyclase-C Agonists Product Overview
Table 141. Kyowa Kirin Co. Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Kyowa Kirin Co. Business Overview
Table 143. Kyowa Kirin Co. Recent Developments
Table 144. Ltd. Basic Information
Table 145. Ltd. Guanylate Cyclase-C Agonists Product Overview
Table 146. Ltd. Guanylate Cyclase-C Agonists Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Ltd. Business Overview
Table 148. Ltd. Recent Developments
Table 149. Global Guanylate Cyclase-C Agonists Sales Forecast by Region (2026-2033) & (K Units)
Table 150. Global Guanylate Cyclase-C Agonists Market Size Forecast by Region (2026-2033) & (M USD)
Table 151. North America Guanylate Cyclase-C Agonists Sales Forecast by Country (2026-2033) & (K Units)
Table 152. North America Guanylate Cyclase-C Agonists Market Size Forecast by Country (2026-2033) & (M USD)
Table 153. Europe Guanylate Cyclase-C Agonists Sales Forecast by Country (2026-2033) & (K Units)
Table 154. Europe Guanylate Cyclase-C Agonists Market Size Forecast by Country (2026-2033) & (M USD)
Table 155. Asia Pacific Guanylate Cyclase-C Agonists Sales Forecast by Region (2026-2033) & (K Units)
Table 156. Asia Pacific Guanylate Cyclase-C Agonists Market Size Forecast by Region (2026-2033) & (M USD)
Table 157. South America Guanylate Cyclase-C Agonists Sales Forecast by Country (2026-2033) & (K Units)
Table 158. South America Guanylate Cyclase-C Agonists Market Size Forecast by Country (2026-2033) & (M USD)
Table 159. Middle East and Africa Guanylate Cyclase-C Agonists Sales Forecast by Country (2026-2033) & (Units)
Table 160. Middle East and Africa Guanylate Cyclase-C Agonists Market Size Forecast by Country (2026-2033) & (M USD)
Table 161. Global Guanylate Cyclase-C Agonists Sales Forecast by Type (2026-2033) & (K Units)
Table 162. Global Guanylate Cyclase-C Agonists Market Size Forecast by Type (2026-2033) & (M USD)
Table 163. Global Guanylate Cyclase-C Agonists Price Forecast by Type (2026-2033) & (USD/Unit)
Table 164. Global Guanylate Cyclase-C Agonists Sales (K Units) Forecast by Application (2026-2033)
Table 165. Global Guanylate Cyclase-C Agonists Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Guanylate Cyclase-C Agonists
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Guanylate Cyclase-C Agonists Market Size (M USD), 2024-2033
Figure 5. Global Guanylate Cyclase-C Agonists Market Size (M USD) (2020-2033)
Figure 6. Global Guanylate Cyclase-C Agonists Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Guanylate Cyclase-C Agonists Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Guanylate Cyclase-C Agonists Product Life Cycle
Figure 13. Guanylate Cyclase-C Agonists Sales Share by Manufacturers in 2024
Figure 14. Global Guanylate Cyclase-C Agonists Revenue Share by Manufacturers in 2024
Figure 15. Guanylate Cyclase-C Agonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Guanylate Cyclase-C Agonists Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Guanylate Cyclase-C Agonists Revenue in 2024
Figure 18. Industry Chain Map of Guanylate Cyclase-C Agonists
Figure 19. Global Guanylate Cyclase-C Agonists Market PEST Analysis
Figure 20. Global Guanylate Cyclase-C Agonists Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Guanylate Cyclase-C Agonists Market Share by Type
Figure 27. Sales Market Share of Guanylate Cyclase-C Agonists by Type (2020-2025)
Figure 28. Sales Market Share of Guanylate Cyclase-C Agonists by Type in 2024
Figure 29. Market Size Share of Guanylate Cyclase-C Agonists by Type (2020-2025)
Figure 30. Market Size Share of Guanylate Cyclase-C Agonists by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Guanylate Cyclase-C Agonists Market Share by Application
Figure 33. Global Guanylate Cyclase-C Agonists Sales Market Share by Application (2020-2025)
Figure 34. Global Guanylate Cyclase-C Agonists Sales Market Share by Application in 2024
Figure 35. Global Guanylate Cyclase-C Agonists Market Share by Application (2020-2025)
Figure 36. Global Guanylate Cyclase-C Agonists Market Share by Application in 2024
Figure 37. Global Guanylate Cyclase-C Agonists Sales Growth Rate by Application (2020-2025)
Figure 38. Global Guanylate Cyclase-C Agonists Sales Market Share by Region (2020-2025)
Figure 39. Global Guanylate Cyclase-C Agonists Market Size Market Share by Region (2020-2025)
Figure 40. North America Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Guanylate Cyclase-C Agonists Sales Market Share by Country in 2024
Figure 43. North America Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Guanylate Cyclase-C Agonists Market Size Market Share by Country in 2024
Figure 45. U.S. Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Guanylate Cyclase-C Agonists Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Guanylate Cyclase-C Agonists Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Guanylate Cyclase-C Agonists Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Guanylate Cyclase-C Agonists Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Guanylate Cyclase-C Agonists Sales Market Share by Country in 2024
Figure 53. Europe Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Guanylate Cyclase-C Agonists Market Size Market Share by Country in 2024
Figure 55. Germany Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Guanylate Cyclase-C Agonists Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Guanylate Cyclase-C Agonists Sales Market Share by Region in 2024
Figure 67. Asia Pacific Guanylate Cyclase-C Agonists Market Size Market Share by Region in 2024
Figure 68. China Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Guanylate Cyclase-C Agonists Sales and Growth Rate (K Units)
Figure 79. South America Guanylate Cyclase-C Agonists Sales Market Share by Country in 2024
Figure 80. South America Guanylate Cyclase-C Agonists Market Size and Growth Rate (M USD)
Figure 81. South America Guanylate Cyclase-C Agonists Market Size Market Share by Country in 2024
Figure 82. Brazil Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Guanylate Cyclase-C Agonists Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Guanylate Cyclase-C Agonists Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Guanylate Cyclase-C Agonists Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Guanylate Cyclase-C Agonists Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Guanylate Cyclase-C Agonists Production Market Share by Region (2020-2025)
Figure 103. North America Guanylate Cyclase-C Agonists Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Guanylate Cyclase-C Agonists Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Guanylate Cyclase-C Agonists Production (K Units) Growth Rate (2020-2025)
Figure 106. China Guanylate Cyclase-C Agonists Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Guanylate Cyclase-C Agonists Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Guanylate Cyclase-C Agonists Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Guanylate Cyclase-C Agonists Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Guanylate Cyclase-C Agonists Market Share Forecast by Type (2026-2033)
Figure 111. Global Guanylate Cyclase-C Agonists Sales Forecast by Application (2026-2033)
Figure 112. Global Guanylate Cyclase-C Agonists Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Guanylate Cyclase-C Agonists
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Guanylate Cyclase-C Agonists Market Size (M USD), 2024-2033
Figure 5. Global Guanylate Cyclase-C Agonists Market Size (M USD) (2020-2033)
Figure 6. Global Guanylate Cyclase-C Agonists Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Guanylate Cyclase-C Agonists Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Guanylate Cyclase-C Agonists Product Life Cycle
Figure 13. Guanylate Cyclase-C Agonists Sales Share by Manufacturers in 2024
Figure 14. Global Guanylate Cyclase-C Agonists Revenue Share by Manufacturers in 2024
Figure 15. Guanylate Cyclase-C Agonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Guanylate Cyclase-C Agonists Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Guanylate Cyclase-C Agonists Revenue in 2024
Figure 18. Industry Chain Map of Guanylate Cyclase-C Agonists
Figure 19. Global Guanylate Cyclase-C Agonists Market PEST Analysis
Figure 20. Global Guanylate Cyclase-C Agonists Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Guanylate Cyclase-C Agonists Market Share by Type
Figure 27. Sales Market Share of Guanylate Cyclase-C Agonists by Type (2020-2025)
Figure 28. Sales Market Share of Guanylate Cyclase-C Agonists by Type in 2024
Figure 29. Market Size Share of Guanylate Cyclase-C Agonists by Type (2020-2025)
Figure 30. Market Size Share of Guanylate Cyclase-C Agonists by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Guanylate Cyclase-C Agonists Market Share by Application
Figure 33. Global Guanylate Cyclase-C Agonists Sales Market Share by Application (2020-2025)
Figure 34. Global Guanylate Cyclase-C Agonists Sales Market Share by Application in 2024
Figure 35. Global Guanylate Cyclase-C Agonists Market Share by Application (2020-2025)
Figure 36. Global Guanylate Cyclase-C Agonists Market Share by Application in 2024
Figure 37. Global Guanylate Cyclase-C Agonists Sales Growth Rate by Application (2020-2025)
Figure 38. Global Guanylate Cyclase-C Agonists Sales Market Share by Region (2020-2025)
Figure 39. Global Guanylate Cyclase-C Agonists Market Size Market Share by Region (2020-2025)
Figure 40. North America Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Guanylate Cyclase-C Agonists Sales Market Share by Country in 2024
Figure 43. North America Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Guanylate Cyclase-C Agonists Market Size Market Share by Country in 2024
Figure 45. U.S. Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Guanylate Cyclase-C Agonists Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Guanylate Cyclase-C Agonists Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Guanylate Cyclase-C Agonists Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Guanylate Cyclase-C Agonists Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Guanylate Cyclase-C Agonists Sales Market Share by Country in 2024
Figure 53. Europe Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Guanylate Cyclase-C Agonists Market Size Market Share by Country in 2024
Figure 55. Germany Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Guanylate Cyclase-C Agonists Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Guanylate Cyclase-C Agonists Sales Market Share by Region in 2024
Figure 67. Asia Pacific Guanylate Cyclase-C Agonists Market Size Market Share by Region in 2024
Figure 68. China Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Guanylate Cyclase-C Agonists Sales and Growth Rate (K Units)
Figure 79. South America Guanylate Cyclase-C Agonists Sales Market Share by Country in 2024
Figure 80. South America Guanylate Cyclase-C Agonists Market Size and Growth Rate (M USD)
Figure 81. South America Guanylate Cyclase-C Agonists Market Size Market Share by Country in 2024
Figure 82. Brazil Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Guanylate Cyclase-C Agonists Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Guanylate Cyclase-C Agonists Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Guanylate Cyclase-C Agonists Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Guanylate Cyclase-C Agonists Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Guanylate Cyclase-C Agonists Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Guanylate Cyclase-C Agonists Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Guanylate Cyclase-C Agonists Production Market Share by Region (2020-2025)
Figure 103. North America Guanylate Cyclase-C Agonists Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Guanylate Cyclase-C Agonists Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Guanylate Cyclase-C Agonists Production (K Units) Growth Rate (2020-2025)
Figure 106. China Guanylate Cyclase-C Agonists Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Guanylate Cyclase-C Agonists Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Guanylate Cyclase-C Agonists Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Guanylate Cyclase-C Agonists Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Guanylate Cyclase-C Agonists Market Share Forecast by Type (2026-2033)
Figure 111. Global Guanylate Cyclase-C Agonists Sales Forecast by Application (2026-2033)
Figure 112. Global Guanylate Cyclase-C Agonists Market Share Forecast by Application (2026-2033)
